Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trials.

Zhang CH, Xu GL, Jia WD, Li JS, Ma JL, Ge YS.

Int J Cancer. 2011 Sep 1;129(5):1254-64. doi: 10.1002/ijc.25767. Epub 2011 Jan 6.

2.

Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis.

Miao RY, Zhao HT, Yang HY, Mao YL, Lu X, Zhao Y, Liu CN, Zhong SX, Sang XT, Huang JF.

World J Gastroenterol. 2010 Jun 21;16(23):2931-42.

3.

Meta-analysis: reduced incidence of hepatocellular carcinoma in patients not responding to interferon therapy of chronic hepatitis C.

Miyake Y, Iwasaki Y, Yamamoto K.

Int J Cancer. 2010 Aug 15;127(4):989-96. doi: 10.1002/ijc.25090.

4.

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS.

J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x.

PMID:
21070361
5.

Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis.

Yang YF, Zhao W, Zhong YD, Xia HM, Shen L, Zhang N.

J Viral Hepat. 2009 Apr;16(4):265-71. doi: 10.1111/j.1365-2893.2009.01070.x. Epub 2009 Feb 12.

PMID:
19220736
6.

[Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].

Schott E, Bergk A, Berg T.

Z Gastroenterol. 2008 Jan;46(1):69-80. doi: 10.1055/s-2007-963684. Review. German.

PMID:
18188819
7.

Does antiviral therapy prevent hepatocellular carcinoma?

Kwon H, Lok AS.

Antivir Ther. 2011;16(6):787-95. doi: 10.3851/IMP1895. Review.

PMID:
21900710
8.
9.

Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.

Xu J, Li J, Chen J, Liu ZJ.

Adv Clin Exp Med. 2015 Mar-Apr;24(2):331-40. doi: 10.17219/acem/29760. Review.

10.

Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma.

Hsu CS, Chao YC, Lin HH, Chen DS, Kao JH.

Sci Rep. 2015 May 12;5:9954. doi: 10.1038/srep09954. Review.

11.

Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach.

Cammà C, Giunta M, Andreone P, Craxì A.

J Hepatol. 2001 Apr;34(4):593-602.

PMID:
11394661
12.

Natural course of asymptomatic hepatitis C virus-infected patients and hepatocellular carcinoma after interferon therapy.

Okanoue T, Minami M, Makiyama A, Sumida Y, Yasui K, Itoh Y.

Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S89-91.

PMID:
16234069
13.

Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis.

Zhuang L, Zeng X, Yang Z, Meng Z.

PLoS One. 2013 Sep 17;8(9):e61361. doi: 10.1371/journal.pone.0061361. eCollection 2013. Review.

14.

Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma.

Jeong SC, Aikata H, Katamura Y, Azakami T, Kawaoka T, Saneto H, Uka K, Mori N, Takaki S, Kodama H, Waki K, Imamura M, Shirakawa H, Kawakami Y, Takahashi S, Chayama K.

World J Gastroenterol. 2007 Oct 28;13(40):5343-50.

15.

Role of antiviral therapy in the management of hepatocellular carcinoma.

Guan YS, He Q.

Anticancer Drugs. 2013 Apr;24(4):337-43. doi: 10.1097/CAD.0b013e32835ec39a. Review.

PMID:
23388161
16.

Efficacy of antiviral therapy with nucleotide/nucleoside analogs after curative treatment for patients with hepatitis B virus-related hepatocellular carcinoma: A systematic review and meta-analysis.

Xia BW, Zhang YC, Wang J, Ding FH, He XD.

Clin Res Hepatol Gastroenterol. 2015 Sep;39(4):458-68. doi: 10.1016/j.clinre.2014.12.003. Epub 2015 Jan 28. Review.

PMID:
25650304
17.

Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection.

Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H.

J Med Virol. 2007 Oct;79(10):1485-90.

PMID:
17705189
18.
19.

Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.

Squadrito G, Cacciola I, Alibrandi A, Pollicino T, Raimondo G.

J Hepatol. 2013 Oct;59(4):696-700. doi: 10.1016/j.jhep.2013.05.043. Epub 2013 Jun 7. Erratum in: J Hepatol. 2014 Jan;60(1):238.

PMID:
23751755
20.

Effect of previous interferon treatment on outcome after curative treatment for hepatitis C virus-related hepatocellular carcinoma.

Miyatake H, Kobayashi Y, Iwasaki Y, Nakamura S, Ohnishi H, Kuwaki K, Toshimori J, Hagihara H, Nouso K, Yamamoto K.

Dig Dis Sci. 2012 Apr;57(4):1092-101. doi: 10.1007/s10620-011-1934-1. Epub 2011 Oct 12.

PMID:
21989822

Supplemental Content

Support Center